All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Astellas Pharma Inc. revenue reports

Astellas Pharma Inc. financial reports, Astellas Pharma Inc. annual revenue in 2020. When does Astellas Pharma Inc. report revenue?
Add to widgets
Added to widgets

Astellas Pharma Inc. total revenue, net income and dynamics of changes in US dollar today

Astellas Pharma Inc. revenue for the past few reporting periods. The dynamics of Astellas Pharma Inc. net revenue increased by 21 729 000 000 $ from the last reporting period. These are the main financial indicators of Astellas Pharma Inc.. Astellas Pharma Inc. online financial report chart. Astellas Pharma Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Astellas Pharma Inc. total revenue on the graph is shown in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 3 138 290 674.41 $ -5.55 % ↓ 570 854 855.52 $ -29.857 % ↓
30/09/2019 2 936 578 228.39 $ -0.527 % ↓ 649 900 438.75 $ +41.99 % ↑
30/06/2019 3 101 798 814.44 $ +1.53 % ↑ 543 228 354.56 $ +7.26 % ↑
31/03/2019 2 797 183 222.20 $ - 285 269 615.09 $ -
31/12/2018 3 322 717 991.13 $ - 813 839 957.21 $ -
30/09/2018 2 952 127 418.28 $ - 457 721 734.82 $ -
30/06/2018 3 054 928 450.41 $ - 506 476 567.83 $ -
Show:
to

Astellas Pharma Inc. financial report charts

The latest dates of Astellas Pharma Inc. financial statements available online: 30/06/2018, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Astellas Pharma Inc. is 31/12/2019. Gross profit Astellas Pharma Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Astellas Pharma Inc. is 255 295 000 000 $

Astellas Pharma Inc. quarterly report dates

Cost of revenue Astellas Pharma Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Astellas Pharma Inc. is 82 770 000 000 $ Total revenue Astellas Pharma Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Astellas Pharma Inc. is 338 065 000 000 $ Operating revenue Astellas Pharma Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Astellas Pharma Inc. is 338 065 000 000 $

Operating income Astellas Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Astellas Pharma Inc. is 76 154 000 000 $ Net income Astellas Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Astellas Pharma Inc. is 61 494 000 000 $ Current assets Astellas Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Astellas Pharma Inc. is 834 150 000 000 $

31/12/2019 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 369 928 616.46 $ 2 301 985 618.97 $ 2 447 228 977.18 $ 2 199 917 951.61 $ 2 541 350 312.27 $ 2 276 280 719.39 $ 2 398 279 199.10 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
768 362 057.95 $ 634 592 609.42 $ 654 569 837.26 $ 597 265 270.59 $ 781 367 678.87 $ 675 846 698.89 $ 656 649 251.31 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 138 290 674.41 $ 2 936 578 228.39 $ 3 101 798 814.44 $ 2 797 183 222.20 $ 3 322 717 991.13 $ 2 952 127 418.28 $ 3 054 928 450.41 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
3 138 290 674.41 $ 2 936 578 228.39 $ 3 101 798 814.44 $ 2 797 183 222.20 $ 3 322 717 991.13 $ 2 952 127 418.28 $ 3 054 928 450.41 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
706 945 078.67 $ 796 378 449.04 $ 722 364 305.18 $ 667 853 951.13 $ 770 775 663.54 $ 590 804 234.07 $ 592 270 963.63 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
570 854 855.52 $ 649 900 438.75 $ 543 228 354.56 $ 285 269 615.09 $ 813 839 957.21 $ 457 721 734.82 $ 506 476 567.83 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
508 528 132.59 $ 477 773 227.46 $ 496 710 748.27 $ 545 131 389.74 $ 467 803 179.73 $ 440 325 208.35 $ 483 946 487.92 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 431 345 595.74 $ 2 140 199 779.34 $ 2 379 434 509.26 $ 2 129 329 271.07 $ 2 551 942 327.59 $ 2 361 323 184.20 $ 2 462 657 486.78 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
7 743 496 564.44 $ 7 942 581 893.60 $ 7 613 347 524.30 $ 7 957 091 376.47 $ 8 264 352 651.76 $ 7 848 989 695.12 $ 7 841 748 878.34 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
18 471 314 332.55 $ 18 378 826 822.79 $ 17 888 818 471.58 $ 17 616 053 190.10 $ 17 900 830 800.97 $ 17 516 519 808.61 $ 17 327 376 677.88 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
2 577 006 693.38 $ 2 890 450 512.23 $ 2 408 239 963.72 $ 2 887 730 564.39 $ 3 075 453 381.06 $ 2 848 676 569.25 $ 2 875 356 194.17 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
4 326 462 293.15 $ 4 489 547 766.56 $ 4 308 861 538.51 $ 4 602 179 599.94 $ 4 591 346 224.06 $ 4 154 929 200.16 $ 4 072 003 281.79 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
6 241 333 424.04 $ 6 346 678 025.14 $ 6 287 656 085.26 $ 5 934 239 244.52 $ 5 905 127 447.80 $ 5 609 228 685 $ 5 482 876 432.12 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
33.79 % 34.53 % 35.15 % 33.69 % 32.99 % 32.02 % 31.64 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
12 229 980 908.51 $ 12 032 148 797.64 $ 11 601 162 386.33 $ 11 681 813 945.58 $ 11 995 703 353.16 $ 11 907 291 123.61 $ 11 844 500 245.76 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
637 108 329.09 $ 874 904 178.76 $ 68 806 325.64 $ 510 096 976.23 $ 850 285 401.69 $ 695 369 054.91 $ 345 136 316.93 $

Last revenue report of Astellas Pharma Inc. was 31/12/2019. According to last financial report total revenue in Astellas Pharma Inc. was 3 138 290 674.41 US dollar and changed by -5.55% since last year. Net income in Astellas Pharma Inc. was 570 854 855.52 $ in last quartal, net income changes to -29.857%.

Total assets Astellas Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Astellas Pharma Inc. is 1 989 779 000 000 $ Current cash Astellas Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Astellas Pharma Inc. is 277 602 000 000 $ Current debt Astellas Pharma Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Astellas Pharma Inc. is 466 058 000 000 $

Astellas Pharma Inc. stocks data

Astellas Pharma Inc. financials